PAMA Resource Center
Find white papers, videos, and tools to help your lab survive and thrive in the PAMA era.
Reimbursement for laboratory testing stands to undergo an unprecedented decrease starting January 1, 2018. This is when the new Medicare clinical laboratory fee schedule goes into effect under the Protecting Access to Medicare Act (PAMA). Bottom lines will certainly be impacted, but labs can minimize the effect of reimbursement cuts by proactively investigating opportunities for efficiency gains and partnering with vendors who will provide consultative, comprehensive solutions for implementing automated processes to improve operational and reagent efficiencies, testing utilization, and costs.
The resources below are designed to help you prepare for the coming changes and minimize the impact to your bottom line.
Ready for PAMA: Testimonial Video from Covenant Health
Hear how one of the largest reference labs in the southwestern U.S. has optimized efficiency and reduced costs, after partnering with Siemens Healthineers on workflow improvements and PAMA readiness.
PAMA Survival 101: White Paper and Preparedness Checklist
Access our 15-point checklist to ready your lab for PAMA’s impact, and read the white paper outlining the history of the clinical lab fee schedule (CLFS), what changes to expect in the coming years, what you can do now – and how to leverage vendor partnerships to help.
Lab Test Utilization and PAMA White Paper
Lab test utilization (LTU) supports the transition to fee-for-value payment models that aim to improve patient outcomes, increase quality of care, and reduce costs which mitigates PAMA reimbursement cuts. Download the white paper to understand how these topics merge as a long-term, value-based strategy.
Infographic: Send-out versus In-house Testing
Using testing for co-occurring conditions in a hospitalized diabetic patient as an example, see how a robust assay menu can help reduce cost per test, support faster diagnoses, and expedite time to treatment.